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Abstract: - The COVID-19 Pandemic has affected many sectors of the healthcare system, most especially the laboratory. 
Adjustments are made in order to cater to this situation, notably the pre-analytical phase, the part of the laboratory procedure most 
vulnerable to frequent errors. This study aims to determine how medical technologists collect, handle, and transport clinical 
specimens in laboratories in Metro Manila during the COVID-19 pandemic. A descriptive cross-sectional study was conducted. The 
survey used was adapted from De Gruyter (2020) and the World Health Organization (WHO). Respondents were recruited through 
emails to the medical directors of their institutions and contacted through Facebook through posting. Respondents fitting the inclusive 
criteria were asked for their consent to participate in an online survey given through Google Forms and informed of the nature of 
said study. The survey questionnaire was divided into five categories, which included the demographic profile, specimen collection, 
specimen handling, specimen transport, and specimen personal protective equipment. Through quantitative statistics and descriptive 
analysis, the questions were tallied, weighed, and averaged using the scoring system given by the WHO. Most respondents practice 
proper documentation, including minimum patient identification, and use special labels for patient samples. They have guidelines in 
specimen quality, adequate storage for analyzed and unanalyzed specimens. Most laboratory specimens are transported via motorized 
vehicle, with solid-walled leakproof containers being the most used method of packaging specimens. Respondents have personnel 
in charge present in receiving infectious substances. Gloves are the most worn personal protective equipment and Class I Biosafety 
Cabinets, Class 2 Biosafety Cabinets, and negative pressure rooms have the lowest frequency of use. Results from the study have 
determined that most medical technologists practice proper collection procedures, have guidelines in accepting unqualified 
specimens, as well as provide adequate storage for analyzed specimens and those with delayed analysis. The most frequent means 
of specimen delivery is through motorized vehicles, and delivery by hand. The most used packaging used for samples includes solid-
walled leakproof containers, single plastic bags, and three layers of plastic bags. The most used laboratory protection practices used 
are gloves, disposable gowns, and goggles/face shields. The researchers recommend further training for medical technologists in 
both local/national and international regulations, and the inclusion of BSL I and II cabinets with negative pressure rooms. 




Pandemics are considered as a major public health 
crisis since it has the capacity to affect all facets of the society. 
However, there can be significant variations on its effects and 
approaches to address it, mostly depending on the type or 
classification of microorganisms that caused such 
circumstances to occur. [42] This notion can be ideally more 
noticeable from a modern perspective regarding the recent 
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pandemics, particularly those that emerged within the last 
decade.  
COVID-19 is transmissible via airborne droplets [1]. This virus 
primarily infects the epithelial lining of the host’s respiratory 
system causing bronchitis, bronchiolitis, and pneumonia [33]. 
Center for Disease Control and Prevention (CDC) declared that 
COVID-19 is contagious, mostly when the individual is 
symptomatic. Furthermore, CDC identified that individuals 
who are younger than 5 years old and older than 65 years old 
are at high risk of being infected. It also includes individuals 
who have comorbidities and who are pregnant. 
The process of receiving samples by the laboratory is known as 
the pre-analytical phase, where medical technologists 
centrifuge, aliquot, dilute, and sort biological samples sent by 
the patient. It is also where biological samples are collected, 
labelled, and transported as well as choosing and ordering the 
suitable tests to be done [46]. This phase of laboratory testing 
is as crucial as the analytical phase, where most errors (48%-
68%) usually occur in the pre-analytical testing [51]. Since it is 
the most error prone phase among the three phases of laboratory 
testing, it is essential to have strict procedures in place to follow 
in the laboratory to avoid numerous errors that can occur during 
this process. 
While diagnostic errors can happen anywhere and at any time 
in healthcare, the risk of laboratory medicine services is 
increased when staff is expected to work in hostile 
environments, where they are exposed to high workloads and 
are under intense stress, especially today in the Philippines, 
where laboratory facilities are facing large increase of COVID-
19 positive cases needing medical support. A healthcare error, 
regardless of the severity, may have a variety of negative effects 
on a patient's health, including death. False-positive or false-
negative test findings endanger not only the patient's wellbeing, 
but also the effectiveness of public health programs, emergency 
plans, and the restrictive and preventive measures required by 
the national and foreign officials in handling the pandemic [39]. 
A false-positive test result may lead to unnecessary treatment, 
financial losses due to isolation, and psychological damage due 
to isolation and the fear of infecting others. On the other hand, 
false-negative test findings may result in lack of treatment, 
unable to monitor infected patients, and increased risk of spread 
of COVID-19. 
In this study, the researchers aimed to systematically analyze 
the methods implemented and the approaches made by Medical 
Technologists in the pre-analytical phase of laboratories in 
Metro Manila during the emergence of the COVID-19 
pandemic, which can be used as a base of reference for future 
outbreaks. 
II. METHODOLOGY  
2.1 Research Design  
The researchers conducted a descriptive cross-
sectional study, which, according to Setia (2016), involves the 
observation of participants at a specific time. [57] In relation to 
the research objective, the study aims to observe and determine 
how medical technologists handle clinical specimens during the 
COVID-19 pandemic. In the same study conducted by Setia, 
the participants, which in this case are registered medical 
technologists who are in active duty in public and private 
laboratories and hospitals in Metro Manila, are selected based 
on the inclusion and exclusion criteria established specifically 
for the study. The pre-analytical procedures were analyzed 
based on the answers of registered medical technologists 
working in public and private laboratories in Metro Manila. The 
questionnaires were formulated based on a structured survey 
questionnaire adapted from WHO and the “Laboratory 
practices to mitigate biohazard risks during the COVID-19 
outbreak: an IFCC global survey” by De Gruyter (2020) in the 
form of an online survey. The online survey was directly 
distributed through email to medical technologists that are 
currently in active duty during the COVID-19 pandemic in 
Metro Manila. The request for the preferred emails of the 
participants was also included in the letter addressed to the 
medical or hospital directors regarding the request for 
permission to conduct data gathering. After their approval, we 
received their preferred email address and subsequently 
distributed the questionnaire. Additionally, the researchers also 
posted infographics containing details of the data gathering on 
Facebook groups consisting of Filipino Registered Medical 
Technologists (see Appendix G). Once the data was collected, 
it was analyzed through quantitative statistics and descriptive 
analysis to identify and interpret the pre-analytical procedures 
performed by the medical technologists in public and private 
laboratories and hospitals in Metro Manila during the COVID-
19 pandemic. 
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2.2 Subjects and Study Site  
The study utilized purposive sampling, which was 
initiated by establishing a general criterion for the population. 
This was based on the title of the study, indicating medical 
technologists who are working during the COVID-19 pandemic 
in Metro Manila. Furthermore, specific criteria that were 
formulated resulted in the establishment of the inclusion and 
exclusion criteria, allowing the researchers to specifically 
identify the target population, where the sample will be drawn. 
A sample is a small, random portion of the whole population 
representing the entire population. In this case, the target 
population was identified as medical technologists who are 
working in public and private hospitals and laboratories in 
Metro Manila during the COVID-19 pandemic. Consent forms 
were given to the selected qualified participants in which they 
could choose to agree or disagree to participate in the study. 
There were no gender restrictions, and the preferred age of the 
participants would be between 21 - 64 years old. Registered 
medical technologists who are working in public and private 
hospitals and clinical laboratories outside of Metro Manila were 
excluded. 
2.3 Data and Instrumentation  
 The study utilized survey questionnaires through 
Google Forms as the platform to conduct data gathering. The 
survey questionnaire was constructed with seven sections 
which can be answered and submitted within five minutes. The 
sections were organized chronologically into greetings (section 
I), informed consent (section II), demographics (section III), 
and survey questions (sections IV, V, VI, and VII). To 
emphasize, the demographics include participant’s full name, 
age, sex, and the name of the hospital where they are working. 
All of the questions about the participant’s demographics are 
required, except the participant’s full name. Furthermore, the 
survey questions consist of eleven items in the form of Likert-
Scale and select-all-that-apply (SATA) questions. The data 
collected were then encoded and tallied in Microsoft Excel. In 
addition, questions consisting of the choices yes, partial, no, or 
non-applicable, the respective categories these questions were 
in are averaged and graded accordingly. 
Prior to the actual data gathering, the researcher performed pilot 
testing among 25 registered medical technologists to determine 
if the study questionnaire is feasible, measurable, attainable, 
and realistic. The study sample size consists of 94 respondents 
which was calculated from the established margin of error 
(10%) approved by the statistician and the research adviser, 
with a 95% confidence level in a population of 3738 registered 
medical technologists. The latter population was based on the 
total population of registered medical technologists in Metro 
Manila as per DOH 2020.  
After conducting pilot testing, the internal consistency of the 
questionnaire was checked using Cronbach’s Alpha. It attained 
a value of 0.608 which is satisfactory according to Taber [42].  
Cronbach’s alpha is a statistic commonly quoted by authors to 
demonstrate that tests and scales that have been constructed or 
adopted for research projects are fit for purpose. 
Table.1. Reliability Statistics 
 
Alpha values are described as 
 Excellent (0.93–0.94), 
 strong (0.91–0.93), 
 reliable (0.84–0.90), 
 robust (0.81), 
 fairly high (0.76–0.95), 
 high (0.73–0.95), 
 good (0.71–0.91), 
 relatively high (0.70–0.77), 
 slightly low (0.68), 
 reasonable (0.67–0.87), 
 adequate (0.64–0.85), 
 moderate (0.61–0.65), 
 satisfactory (0.58–0.97), 
 acceptable (0.45–0.98), 
 sufficient (0.45–0.96), 
 not satisfactory (0.4–0.55) and 
 low (0.11) 
2.4 Data Gathering Procedure  
 The researchers requested permission to administer a 
survey to the employed medical technologist of public and 
private hospitals and laboratories from either the hospital or 
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laboratory director through email, phone, or telephone call of 
the contact numbers of their respective institutions. The 
researchers also requested a list of their medical technologist's 
preferred email addresses to directly distribute the survey 
questionnaires to the participants. After permission was granted 
to conduct a survey among the medical technologists of the 
respective hospitals, a Google form, consisting of the informed 
consent and the survey questions, was sent directly to the 
participants (i.e., medical technologists) of the study via email. 
Additionally, the researchers also posted infographics 
containing details of their data gathering on Facebook groups 
consisting of Filipino Registered Medical Technologists (see 
Appendix G), to request for respondents. The informed consent 
must be accomplished first prior to answering the 
demographics and survey questions. 
2.5 Ethical Consideration  
An initial copy of this study was given to the Ethics 
Committee for research approval. Before the survey proper, 
participants were given consent forms for them to be properly 
informed about the study, as well as for them to understand the 
information, and have the freedom to choose whether to take 
part or not. The participants’ permission to participate in this 
study was only received after a detailed explanation of the 
research process. These participants were specifically informed 
that they had the right to withdraw from the study at any time, 
even after agreeing to the informed consent. Participants were 
kept anonymous and their personal data and responses to the 
survey were kept confidential by not disclosing their names and 
identities in the data collection, interpretation, and reporting of 
the study results. Furthermore, gender neutral pronouns were 
used to protect their anonymity and confidentiality. 
2.6 Data Analysis  
 All data from the participants were analyzed 
quantitatively, particularly through descriptive statistics used in 
conjunction with percentages, weighted mean, and frequency 
tables. The researchers utilized the accounts and cases of the 
participants in attempting to form relationships and a 
framework of knowledge based on their responses. The 
collected data were tallied by the researchers. Subsequently, the 
calculations of the data gathered was computed with the help of 
the hired statistician, alongside the formulation of tables and 
charts necessary for data illustration and efficient 
interpretation. The researchers utilized statistical analyses such 
as weighted mean, and frequencies in gauging the pre-
analytical competencies of the respondents. Questions 
containing the options yes, no, partial, not applicable were 
calculated accordingly with responses of: 
 Yes - giving 1 point or 100% to the question 
 Partial - giving 0.5 points or 50% to the question 
 No - giving 0 points or 0% to the question 
 Non-applicable - excluding the question from the 
calculation 
In summarizing results using the questions above, the responses 
are averaged per category and assessed using these conditions:  
 Below 50% - requires significant improvement 
 Between 50% and 80% - some improvement is 
necessary 
 Above 80% - the laboratory is in good standing 
III. RESULTS  
3.1 Demographic Profile 
Table.1. Demographic Profile of the Respondents 
Age Mean SD 
Age 27.14 6.5 
Sex f % 
Male 33 42.86 
Female 44 57.14 
Total 77 100 
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Table.1. displays the demographic profile of the respondents 
using frequency and percentage. It shows that there are a total 
of 77 medical technologists who answered the survey, with 
majority of the respondents being female (57.14 %) with a 
mean age of 27.14. 
3.2 Specimen Collection 
 
Fig.1. Documentation and availability of collection procedures 
 
Fig.2. Inclusion of minimum patient identification details in 
collection procedures 
 
Fig.3. Use of special labels for patient samples 
The documentation of collection procedures and its availability 
to relevant personnel is observed in 72 or 94% of the 
participants (Figure 1). In 97% of the time, this includes 
recording the minimum details to identify patients (Figure 2). 
In terms of labelling samples, 74 or 96% responded that they 
indicate with special labels using stickers or hand-written 
symbols or label the samples that they obtained from their 
patients (Figure 3). Minimum patient identification is observed 
in most laboratory specimens (97%), while seldom is it partially 
observed (3%). The average score for specimen collection is 
97%  which corresponds to a good laboratory standing.  
3.3 Specimen Handling 
 
Fig.4. Availability of criteria to accept or reject primary specimens 
 
Fig.5. Presence of adequate storage for specimens if not examined 
immediately 
 
Fig.6. Presence of adequate storage for analyzed specimens 
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In Figure 4, it can be observed that 97% of the participants are 
using a set of criteria when accepting or rejecting primary 
specimens (including potential caution if non-conforming 
specimens). The storages of primary specimens which are not 
examined immediately, and which are already analyzed are 
adequate in 94% and 90% of the time, respectively (Figures 5 
and 6). The average score for specimen handling is 96% which 
corresponds to a good laboratory standing. 
3.4 Specimen Transport 
 
Fig.7. Delivery of biochemistry samples 
 
Fig.8. Packaging methods of biochemistry samples 
Figure 7 presents the different ways on how clinical 
specimen samples were delivered. The most frequent way to 
deliver the biochemistry samples was by motorized vehicle 
with 48 frequency or 62.3% and followed by transporting by 
hand with 44 frequency or 57.1%. Figure 8 shows the ways on 
how the samples were packed for delivery. A total of 52 or 
67.5% of respondents reported that the samples in plastic bags 
were placed in solid-walled, leak-proof containers. 
 
Fig.9. Presence of person/s-in-charge of shipments of infectious 
substances. 
 
Fig.10. Training of staff for local or national regulations 
 
Fig.11. Training of staff for international regulations 
Majority (72%) of the participants indicated that there is/are 
person/s-in-charge of shipments trained for the transport of 
infectious substances (Figure 9). Among them, 60% have 
answered “yes” for having training for local or national 
regulations and 30% have answered “partial” for having 
training for local or national regulations (Figure 10). Figure 11 
shows that only 30% of the respondents have answered “yes” 
for being trained in international regulations and 34% have 
answered “partial” for having training in international 
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regulations. The average indicator for this area of specimen 
transport is 70%, which implies that some improvements must 
be made. 
3.5 Specimen Personal Protective Equipment 
 
Fig.12. Frequency of protection processes employed when handling 
clinical specimen samples. 
Figure 12 shows the frequency of protection processes 
utilized by the laboratory staff when manually handling 
specimen samples during this COVID-19 pandemic. Seventy-
six or 98.7% of the medical technologists who participated in 
this study reported that gloves are the most commonly worn 
personal protective equipment (PPE) in their protection 
process. The least employed protection process in the 
laboratory is the use of class I biosafety cabinets with the 
frequency of 14 or 18% of the respondents. 
IV. DISCUSSION 
This study aimed to identify how medical 
technologists in NCR collect, handle, and transport clinical 
specimens during the COVID-19 pandemic. The questionnaire 
used for the study focused on four (4) areas of the pre-analytical 
phase: specimen collection, specimen handling, specimen 
transport, and personal protective equipment.  
4.1 Demographic Profile 
The demographic profile of the respondents in Table 2 
corresponds to the requirements of the study which include both 
sexes and comprises ages ranging from 21-64 years of age. The 
youngest respondent from the study was 21 years of age and the 
oldest was 56 years of age at the time of answering. The 
laboratories wherein the respondents were working ranged 
from public and private hospitals within NCR. 
4.2 Specimen Collection 
Among the respondents, the majority observed proper 
practices of specimen collection which include having an 
outline of standard collection procedures, pertinent patient 
identification, and the corresponding labelling with regards to 
the type of specimen submitted to the laboratory based on the 
results in Figures 2, 3, and 4. As major sources of pre-analytical 
errors include identification errors, which may be of the patient 
or of the specimen, the following and knowledge of correct 
procedures for specimen collection remains critical to the 
accuracy of testing [61]. Routine laboratory work includes the 
following of these guidelines, while still adhering to the 
standard operating procedures of the given laboratory as 
advised by the World Health Organization. It is integral that 
staff are trained with regard to the appropriate specimen 
collection practices and are adhering to the given infection 
prevention and control guidelines. Risk assessment should be 
performed in line and updated with existing guidelines to 
ensure the good microbiological practices and procedures in the 
laboratory are held to a high degree. According to the Biosafety 
in Microbiological and Biomedical Laboratories 6th Edition, 
released by the Center for Disease Control and Prevention in 
2020, the minimization and control of risk factors in a 
microbiological setting deal with proper infection control to 
ensure safety together with decontaminating areas of specimen 
collection. With specimen collection differing in specific 
sections of the laboratory, procedures and protocols must be 
known to the laboratory personnel and should be readily 
accessible. In general, the respondents observed the proper 
procedures in specimen collection, through proper 
documentation, labelling and identification. 
4.3 Specimen Handling 
 In the area of specimen handling, the study focused on 
the availability of a criteria for accepting or rejecting primary 
specimens, and the presence of adequate storage for laboratory 
specimens. The results of this study revealed an acquired 
average indicator score of 96.1% for specimen handling which 
indicates that the respective laboratories of the participants are 
generally in “good standing” in this area of the pre-analytical 
process. To establish the importance of having criteria for 
specimen rejection, a study by Dikmen et al., stated that 
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practicing proper rejection and documentation of unacceptable 
clinical specimens is a fundamental step in improving the 
quality of work in a laboratory [29]. In figure 5, with the 
majority or 97% of the respondents attesting that they follow a 
certain criterion for specimen rejection, it is safe to assume that 
their laboratories are working to keep the quality of their service 
at par with the standards and guidelines set by the WHO [70]. 
Moreover, in terms of specimen storage, 94% of the 
respondents revealed that their laboratories are well equipped 
with adequate storage for specimens that cannot be examined 
immediately, while 90% also allot adequate storage for 
specimens that are already analyzed. Based on the guidelines 
for the collection of clinical specimens during field 
investigation of outbreaks released by the World Health 
organization, clinical specimens, especially those that cannot be 
processed immediately must be contained in an appropriate 
medium and must be stored accordingly depending on the 
specimen type’s recommended storage temperature; these 
storage guidelines must, at all times, be followed to ensure the 
viability and integrity of clinical specimens. As shown in 
Figures 6 and 7, the majority of the medical technologists work 
in a laboratory that has adequate storage for both analyzed 
specimens and specimens that cannot be processed 
immediately, indicating that they observe proper specimen 
storage in accordance with the WHO guidelines. 
4.4 Specimen Transport 
In terms of specimen transport, the study is centered 
on delivery and packaging methods of biochemistry specimens, 
as well as the presence of person/s in-charge of transport of 
infectious specimens. Furthermore, the study also determined if 
the person in-charge of transport is trained for local or national, 
and international regulations.  
The results in Figure 8 showed that the most frequent means of 
transport of biochemistry samples was by motorized vehicle 
(62.3%) and by hand (57.1%). During the pandemic, the 
government had placed the NCR, the region in the Philippines 
with the most cases of COVID-19 [15], into lockdown under 
enhanced community quarantine to contain the spread of virus, 
which also restricted the movements of people residing in the 
capital region. With that said, patients who wish to submit their 
samples cannot travel due to restrictions and the risk of being 
infected. Figure 8 shows that most specimens sent to the 
laboratory are transported via motorized vehicle, implying that 
samples are obtained in the homes of patients to reduce the risk 
of infection or the transmission of the virus if the patient is 
infected. According to Baclig of Inquirer [4], numerous 
hospitals in the National Capital Region have declared full 
capacity for COVID-19 cases, which implies that majority of 
these hospitals would no longer accept COVID-19 patients, but 
some are still willing to accept non-COVID-19 cases, either 
outpatient or inpatient. Regardless of whether some hospitals 
are still accepting COVID-19 or non-COVID-19 cases, some 
people are afraid to visit the hospital. As mentioned in the study 
conducted by Lazerrini et al. [37], people avoid going to the 
hospitals because of their fear of contracting COVID-19. The 
fear of COVID-19 can lead people to decline their treatment 
since they are unable to visit hospitals for their routine 
checkups. Hence, it can be concluded that patients and 
healthcare workers came into an agreement that the medical 
worker would be the one who would visit the houses of the 
patients to collect specimens needed for the laboratory test 
requested by the patients and still be able to monitor their health 
conditions without them going to the hospital. With that, 
healthcare workers would be needing a motorized vehicle as a 
courier to be able to transport the collected specimens from one 
house to their hospital.  
Moreover, according to WHO [71], the probability of being 
infected by COVID-19 increases when people are in proximity 
for an extended amount of time, confined in an enclosed area 
with inadequate ventilation or staying in a crowded place. Thus, 
it can also be interpreted that to avoid 
congestion or influx of people in one area and to lessen the 
spread of the virus, health workers should visit the patient’s 
residence to collect samples for the laboratory test requested by 
the patient and deliver the collected specimen to the laboratory 
by a motorized vehicle. 
The results in Figure 9 revealed that most biochemistry samples 
that are sent in the hospitals or laboratories in NCR are placed 
in solid-walled, leak-proof containers and packed in plastic 
bags. This is in accordance with CDC standards for the storage 
and handling of clinical specimens during an outbreak of a 
respiratory disease when the pathogen is unknown. Also, 
according to University Hospitals Bristol [66], collected 
samples should be kept in leak-proof tubes or bottles that are 
placed inside leak-proof plastic bags to reduce the risk of 
infection to the public and among those medical workers who 
transport the sample since the collected specimens could 
contain infectious agent that is capable of infecting others. 
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Therefore, it is implied that most hospitals and laboratories in 
the NCR follow the standards of CDC in terms of packaging 
and transport of clinical specimens during this time of 
pandemic to reduce the risk of infecting more people. 
As infectious substances always pose a biochemical threat even 
in transit, regulations must be set into place surrounding the 
transport for these infectious agents. As expressed by the CDC 
[70], “...shippers and carriers must be trained on these 
regulations so that they can properly prepare shipments and 
recognize and respond to the risks posed by these materials.” 
As such, the individuals in charge of shipping these infectious 
substances, as well as the training of the staff regarding both 
national and international regulations, contribute to managing 
risk in the laboratory and to the surrounding community. The 
WHO specifically advises that personnel competence and 
training are among the core requirements for achieving 
laboratory biosafety. In general, all personnel handling 
biological agents should be trained on good microbiological 
practices and procedures. Furthermore, competency and 
proficiency assessment are used and verified among personnel 
with corresponding regular review and refresher training. The 
implementation of new procedures must be communicated to 
personnel-in-charge as new information regarding practices 
and standards emerge. As most facilities and laboratories are 
expected to develop their own respective biosafety program, it 
is expected that the management and leadership are responsible 
for its implementation. Figures 10 and 11 depict that laboratory 
possess adequate competencies in dealing with the shipments 
of infectious substances on the local or national level. As seen, 
persons dealing with shipments of infectious substances are 
mostly present, and the staff are trained at the local or national 
regulation competency. Regarding international regulations in 
Figure 12, the majority have received full or partial training in 
said competency, but almost a quarter of the respondents have 
not.  
4.5 Laboratory Protection Processes 
In terms of laboratory protection processes, the results 
show that the most employed protection process in the 
laboratory is the use of personal protective equipment. This 
includes the gloves, disposable gowns, goggles/face shields, 
surgical face masks, N95/equivalent face masks, and disposable 
shoe covers. According to a study by Liu et al. (2020), the risk 
of contracting infections among medical professionals during 
the pandemic cannot be eliminated; however, the use of 
personal protective equipment appropriate against specific 
agents can significantly reduce the risk of infection. 
Additionally, during this COVID-19 pandemic, where the 
healthcare setting requires stronger infection and control 
measures, PPEs are considered as a fundamental element that 
protects health care professionals, patients, and the wider 
community [25]. 
As seen in Figure 13, the least worn PPE, which are the 
disposable shoe covers, are still being worn by the majority or 
74% of the respondents. This only implies that generally, 
medical technologists value the use of personal protective 
equipment when handling clinical specimens. 
However, in Figure 13, it can also be observed that only 18% 
and 37% of the respondents make use of class I biosafety 
cabinets and negative pressure rooms in their designated 
laboratories, respectively. Unlike the PPEs, only a small portion 
of the participants use these protection processes despite its 
importance in laboratory safety. Negative pressure rooms, 
through high-efficiency particulate air filters, are effective in 
minimizing the exposure of medical professionals to hazardous 
fumes and air-borne by-products. Moreover, as stated by Qasmi 
et al. [2], biosafety cabinets have become a standard primary 
barrier against infectious agents in the laboratory. With the 
limited frequency of biosafety cabinets and negative pressure 
rooms among the laboratories of the respondents, the level of 
safety in their workplace also goes down. With this, it can be 
assumed that the protection processes implemented by the 
respondents’ laboratories are not completely safe and effective. 
4.6 Study Limitations 
Due to the pandemic, the researchers encountered 
limitations in acquiring the desired number of respondents for 
the study. The researchers were unable to obtain the desired 
number of respondents. Out of the desired 94 respondents, only 
77 agreed to participate and share their data. Despite the efforts 
of the group in contacting laboratories and hospitals all over 
Metro Manila, most of them were not responding in both calls 
and emails most likely due to the increasing demand of health 
services making laboratories busy during this pandemic. 
Additionally, each health institution has their own procedures 
and protocols in terms of approving data gathering in their 
premises, the urgency of addressing which is different in each 
institution. Hence, the responses to requests for data collection 
also vary from weeks to months. 
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V. CONCLUSION   
The results of the study have determined how medical 
technologists in Metro Manila collect, handle and transport 
clinical specimens during this COVID-19 pandemic. In terms 
of the procedures employed, most medical technologists 
confirmed the practice of collection procedures such as the 
documentation, inclusion of patient identification and 
utilization of special labels for patient’s samples.  
The study has also determined that most medical technologists 
in Metro Manila have guidelines in accepting unqualified 
specimens, as well as adequate storage for analyzed specimens 
and those with delayed analysis.  
The most frequent means by which specimens are delivered to 
the laboratory is through motorized vehicles followed by 
delivery by hand. In terms of material used for packaging the 
specimens, the most used according to the medical 
technologists is the solid-walled leak proof container, followed 
by a single plastic bag and three layers of plastic bag 
respectively. The most evident findings can be seen regarding 
the training for local and international regulations for the staff 
in charge of transporting infectious substances. Although the 
majority has had training for local or national regulations, not 
all have the necessary training for international regulations.  
The PPEs being used are similar for all respondents, while some 
labs have more advanced equipment, such as BSL I and II 
cabinets and a negative pressure room. The common PPEs 
being used among the respondents are gloves, followed by 
disposable gowns, goggles/face shields, surgical face masks, 
N95/equivalent face masks, and disposable shoe covers 
respectively.  
Given the current circumstances and limitations posed to the 
researchers during the COVID-19 pandemic, we recommend 
the following: 
For future investigators, they are recommended to focus on the 
Analytical and Post-Analytical procedures among Medical 
Technologists during the COVID-19 Pandemic in Manila, 
expand the scope to determine how different regions were able 
to handle the pandemic and if there is a difference in analytical 
procedures among these regions, and include the procedures in 
collecting nasopharyngeal specimens, bronchoalveolar lavage 
specimens, and other clinical specimens for COVID-19. 
For the improvement of the study, future researchers are 
advised to increase the number of respondents to provide a 
more reliable and accurate representation of data. As this study 
used an online questionnaire, we recommend including 
interviews with subsequent thematic analysis to provide more 
insight on the data gathered. 
For the improvement of the medical technology profession, 
further training for local or national and international 
regulations for specimen transport requires improvements. 
Laboratories should also include BSL I or II cabinets with 
negative pressure rooms in the facility to ensure better handling 
of specimens and further protection for the personnel. 
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